Literature DB >> 2607320

The role of thrombocytes in liver fibrogenesis: effects of platelet lysate and thrombocyte-derived growth factors on the mitogenic activity and glycosaminoglycan synthesis of cultured rat liver fat storing cells.

M G Bachem1, R Melchior, A M Gressner.   

Abstract

A central problem in the study of the pathogenesis of liver fibrosis (fibrogenesis) is the identification of the cellular sources of the extracellular matrix and the dissection of the molecular mediators stimulating connective tissue synthesis in certain hepatic target cells. In the present study the role of platelets and of some platelet-derived polypeptide growth factors in the proliferation and proteoglycan synthesis of rat liver fat storing cells in culture (the principle connective tissue-producing cell type in liver) was determined. Fat storing cell proliferation was determined by measurement of the DNA-content, and [3H]thymidine- and bromodeoxyuridine-incorporation. Glycosaminoglycan synthesis was determined by the measurement of [35S]sulphate incorporation. Human platelet lysate (0.3 to 2.6 g protein per litre medium) stimulated, in a dose-dependent manner, both the proliferation and glycosaminoglycan synthesis of rat liver fat storing cells kept as a primary culture in Dulbecco's modification of Eagle's medium in the absence of foetal calf serum. More than 70% of the newly synthesized glycosaminoglycans were found in the medium. Among the various thrombocyte-derived polypeptides tested as candidate mediators of the platelet-derived fibrogenic activity, platelet derived growth factor was not effective in enhancing glycosaminoglycan synthesis, and it stimulated the proliferation of fat storing cells only about 2 fold. On the other hand, epidermal growth factor proved to be a stimulus of both processes. Transforming growth factor beta (greater than 10 pmol/l) inhibited foetal calf serum (Dulbecco's modification of Eagle's medium with a fraction of foetal calf serum of 0.1) and epidermal growth factor stimulated proliferation but enhanced the synthesis of sulphated glycosaminoglycans about 2-fold. These results suggest the possible role of transforming growth factor beta as a negative modulator for fat storing cells proliferation but a positive modulator for fat storing cell transformation and extracellular glycosaminoglycan matrix synthesis. Furthermore, our results indicate a cooperation between different hepatic and extrahepatic cell types by paracrine stimulation of fat storing cells. Transforming growth factor beta in combination with epidermal growth factor appear to be candidate mediators of the platelet-derived fibrogenic activity, which stimulates fat storing cells in culture, and might also be effective in vivo during hepatic repair processes following liver injury.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2607320     DOI: 10.1515/cclm.1989.27.9.555

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  13 in total

Review 1.  Targeting Hepatic Fibrosis in Autoimmune Hepatitis.

Authors:  Aldo J Montano-Loza; Ragesh B Thandassery; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-19       Impact factor: 3.199

2.  Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis.

Authors:  M G Bachem; D Meyer; R Melchior; K M Sell; A M Gressner
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 3.  Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.

Authors:  Ki Tae Suk; Dong Joon Kim
Journal:  World J Hepatol       Date:  2015-03-27

4.  Current status of novel antifibrotic therapies in patients with chronic liver disease.

Authors:  Michal Cohen-Naftaly; Scott L Friedman
Journal:  Therap Adv Gastroenterol       Date:  2011-11       Impact factor: 4.409

5.  Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways.

Authors:  Xue-Mei Li; Jing-Hua Peng; Zhao-Lin Sun; Hua-Jie Tian; Xiao-Hua Duan; Lin Liu; Xin Ma; Qin Feng; Ping Liu; Yi-Yang Hu
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

Review 6.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

Review 7.  Hepatic inflammation and progressive liver fibrosis in chronic liver disease.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

8.  Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity.

Authors:  M J Arthur; A Stanley; J P Iredale; J A Rafferty; R M Hembry; S L Friedman
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

Review 9.  Experimental models of liver fibrosis.

Authors:  Sara Crespo Yanguas; Bruno Cogliati; Joost Willebrords; Michaël Maes; Isabelle Colle; Bert van den Bossche; Claudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Ferreira Alves; Isabelle Leclercq; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2015-06-06       Impact factor: 5.153

10.  Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options.

Authors:  Olav A Gressner; Ralf Weiskirchen; Axel M Gressner
Journal:  Comp Hepatol       Date:  2007-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.